Target Ovarian Cancer

Target Ovarian Cancer is the UK's leading ovarian cancer charity. We work to:
- improve early diagnosis
- fund life-saving research
- provide much needed-support to women with ovarian cancer.
We're the only charity fighting ovarian cancer on all three of these fronts, across all four nations of the UK. Ovarian cancer can be devastating. But there is hope - Target Ovarian Cancer. We work with women, family members and health professionals to ensure we target the areas that matter most for those living with ovarian cancer.
We're here to help you access the information and support you need, from coping with a new diagnosis - when it can be hard to take in information and make decisions, through discovering what choices you have, getting through treatment, or dealing with recurrent or incurable ovarian cancer. We hope you will find our resources, wellbeing events and Ask the Experts sessions positive and helpful.
Our confidential support line is also here for anyone affected by ovarian cancer – if you're worried about symptoms, if you have a diagnosis, or if you're a family member or a friend supporting someone living with ovarian cancer. You can speak to one of our specialist nurses by calling 020 7923 5475.
Who to contact
- Telephone
- Support Line: 020 7923 5475
- info@targetovariancancer.org.uk
- Website
- Target Ovarian Cancer
- Notes
You can also get in contact with us on Facebook, Twitter or Instagram.
Where to go
- Name
- Target Ovarian Cancer
- Address
-
30, Angel Gate
City Road
London
- Postcode
- EC1V 2PT
Time / Date Details
- When is it on
- Monday - Friday 9am - 5.30pm
- Time of day
-
Afternoon
Morning
Other Details
Availability
- Other notes
Support groups give you the chance to talk to others who understand what cancer is all about. There are a number of support groups in Liverpool that are specifically for gynaecological cancers. You can search for the closest one to you at targetovariancancer.org.uk/support-groups
Please note that these groups are not run by Target Ovarian Cancer.